Related Experiment Videos

Interaction between polymorphonuclear leukocytes and varicella-zoster virus-infected cells

Intervirology
|January 1, 1985
PubMed

Insights

Polymorphonuclear leukocytes (PMNL) and VZV-specific antibodies reduce varicella-zoster virus (VZV) yield. PMNL activation and phagocytosis of VZV contribute to this antiviral effect.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Varicella-zoster virus (VZV) causes chickenpox and shingles.
  • The immune response to VZV involves both cellular and humoral components.
  • Understanding the interaction between immune cells and infected cells is crucial for antiviral strategies.

Purpose of the Study:

  • To investigate the antiviral effect of polymorphonuclear leukocytes (PMNL) on VZV-infected human fibroblasts.
  • To determine the synergistic effect of PMNL and VZV-specific antibodies in reducing VZV yield.
  • To elucidate the mechanism of PMNL-mediated antiviral activity.

Main Methods:

  • Co-incubation of VZV-infected human fibroblasts with PMNL and/or VZV-specific antibodies.
  • Quantification of VZV yield via virus titration.
  • Morphological analysis of PMNL-VZV-infected cell interactions using electron microscopy.

Main Results:

  • PMNL significantly reduced VZV yield in infected fibroblasts.
  • The addition of VZV-specific antibodies enhanced the antiviral effect of PMNL.
  • VZV-specific antibodies alone also reduced VZV yield, but required higher concentrations.
  • Electron microscopy revealed PMNL adherence, rosette formation, activation, and phagocytosis of VZV virions.

Conclusions:

  • PMNL play a significant role in controlling VZV infection.
  • A combination of PMNL and VZV-specific antibodies provides a potent antiviral effect.
  • PMNL exert antiviral activity through direct interaction and phagocytosis of VZV virions.

Related Concept Videos